The North East Innovation Lab, part of Newcastle Hospitals, has a well-established set of services to support developers in ‘testing the tests’.
The team outside the Biosphere, in Newcastle Helix life sciences quarter
Our services include independent evaluations for new and emerging diagnostics including analytical performance and clinical performance evaluations, developing test protocols and providing control materials, and human sample collection.
We have an HTA-registered biobank containing over 20,000 SAR-Cov-2 samples along with blood, saliva and serum samples, and their associated detailed metadata. This offers clients access to the clinical samples needed to test your products and devices. We can also collect samples prospectively.
Dr Donna Nile, biobank manager takes a sample from the biobank
Since we launched in January 2021 to accelerate the development of Covid diagnostic tests and technologies, the work of our team has expanded to include diagnostics for health and virus threats including hepatitis, cancer, HIV, sepsis, influenza and tropical disease.
We have a global reach having engaged with over 70 potential clients from the USA to Australia from start-ups to international companies.
We’re looking to expand services to meet the needs of the diagnostic industry, to provide tailored and responsive support for a wider range of innovative products throughout the development life cycle. If there is a service you think we could be providing we’d like to hear from you, please get in contact and we can discuss further.
For more information including case studies of our work, please take a look at the flyer attached, visit our website and watch our video which provides more information about how we can support clients.
You can email us at firstname.lastname@example.org or give us a call on +44 (0)191 213 7275.
Follow us on:
Twitter – @Innovlab_ne
Linked In: North East Innovation Lab, part of Newcastle Hospital